Fig. 5.
Anti–TER-119 demonstrates prolonged protection from thrombocytopenia.
SCID mice were injected with 2 μg anti-αIIb antibody on days 1 to 5, day 8, and day 12. On day 2, thrombocytopenic mice were treated with 50 μg anti–TER-119. Mice were bled at the indicated time points. Platelet counts (A) and erythrocyte counts (B) are presented as fold change over untreated control mice; n = 6 for each data point. Nil indicates the mice were not treated with anti–TER-119. Error bars indicate SEM.
